Analgosedation in Critically Ill Adults Receiving Extracorporeal Membrane Oxygenation Support

Area of Science:

• Critical Care Medicine
• Pharmacology
• Cardiopulmonary Support

Background:

• Extracorporeal membrane oxygenation (ECMO) is a vital treatment for severe cardiopulmonary failure.
• Effective analgosedation is critical for patient comfort, ventilator synchrony, and optimizing ECMO therapy.
• Unique pharmacokinetic and pharmacodynamic changes occur in patients receiving ECMO, complicating drug management.

Approach:

• This review synthesizes current knowledge on analgosedation in ECMO patients.
• It examines pharmacological considerations, including drug interactions and altered metabolism.
• The review discusses existing protocols and proposes special considerations for managing analgosedation.

Key Points:

• ECMO circuitry significantly impacts drug absorption, distribution, metabolism, and excretion.
• Standard analgosedation practices may need adjustment in the ECMO population.
• Medication shortages present additional challenges for analgosedation management.

Conclusions:

• Optimizing analgosedation in ECMO requires a thorough understanding of altered drug handling.
• Development of specific clinical guidelines for analgosedation during ECMO is warranted.
• This review provides a framework for clinicians managing analgosedation in critically ill adults on ECMO.